Los puntos clave no están disponibles para este artículo en este momento.
with suitable pharmaceutical properties to warrant further development as an intravenous treatment for COVID-19.
Hoffman et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: